Recombinant Human ACSL4 Protein(Sumo Tag)

Recombinant Human ACSL4 Protein(Sumo Tag)
Artikelnummer
ELSPDEH100661-20
Verpackungseinheit
20μg
Hersteller
Elabscience Biotechnology

Verfügbarkeit: wird geladen...
Preis wird geladen...
Protein Tag: N-Sumo

Uniprot: O60488

Accession: O60488

Background: Activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. Preferentially uses arachidonate and eicosapentaenoate as substrates.Defects in ACSL4 are the cause of mental retardation X-linked type 63 (MRX63) [MIM:300387]. Mental retardation is a mental disorder characterized by significantly sub-average general intellectual functioning associated with impairments in adaptative behavior and manifested during the developmental period. Non-syndromic mental retardation patients do not manifest other clinical signs.Defects in ACSL4 are involved in Alport syndrome with mental retardation midface hypoplasia and elliptocytosis (ATS-MR) [MIM:300194]. A X-linked contiguous gene deletion syndrome characterized by glomerulonephritis, deafness, mental retardation, midface hypoplasia and elliptocytosis.

Bio Acitivity: Not validated for activity

Sequence: Leu184-Tyr277

Purity: > 90% as determined by reducing SDS-PAGE.

Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with 5% Trehalose and 5% Mannitol.

Reconstitution: It is recommended that sterile water be added to the vial to prepare a stock solution of 0.5 mg/mL. Concentration is measured by UV-Vis

Endotoxin: < 10 EU/mg of the protein as determined by the LAL method

Calculated MW: 26.3 kDa

Observed MW: 30 kDa
Mehr Informationen
Artikelnummer ELSPDEH100661-20
Hersteller Elabscience Biotechnology
Hersteller Artikelnummer PDEH100661-20
Verpackungseinheit 20μg
Mengeneinheit STK
Reaktivität Human
Wirt Escherichia Coli
Produktinformation (PDF)
×
MSDS (PDF)
×